ENTERPRISE PRODUCTS PARTNERS L.P. current report, Q1 FY2026

Business Context and Reporting Period

Company: ENTERPRISE PRODUCTS PARTNERS L.P. (EPD)
Filing Type: Form 8-K (Current Report)
Date of Report: March 27, 2026
Event: Entry into a Material Definitive Agreement (364-Day Revolving Credit Agreement).

Key Financial Metrics and Liquidity

  • Facility Size: Up to $1.5 billion, with an option to increase by $200 million to $1.7 billion subject to conditions.
  • Term: 364 days, maturing March 26, 2027.
  • Extension Option: Borrower may elect to convert outstanding principal to non-revolving term loans for one additional year (maturing March 26, 2028).
  • Interest Structure: Variable interest rate based on senior debt credit rating; quarterly facility fees apply regardless of usage.
  • Security: Unsecured by collateral; guaranteed by the Partnership.
  • Outstanding Borrowings: $0 as of March 27, 2026.
  • Permitted Uses: Working capital, capital expenditures, acquisitions, and other corporate purposes.

Material Changes Versus Prior Period

This agreement replaces the existing 364-Day Revolving Credit Agreement dated March 28, 2025, which matured on March 27, 2026. The new agreement maintains the same initial borrowing capacity of $1.5 billion and the same administrative agent (Citibank, N.A.).

Guidance, Risks, and Covenants

  • Distribution Restrictions: The agreement restricts the ability to pay cash distributions to the Partnership if an event of default occurs or would result from such payment.
  • Covenants: Contains customary affirmative and negative covenants and events of default.
  • Default Consequences: Lenders may accelerate the maturity date of borrowed amounts upon an event of default.
  • Management Commentary: The filing does not provide specific forward-looking guidance or commentary beyond the terms of the credit facility.

Investor Verification Checklist

  • Verify the current senior debt credit rating to determine applicable interest rate spreads and facility fees.
  • Confirm the status of any potential $200 million increase to the facility cap.
  • Review the full text of the 364-Day Credit Agreement (Exhibit 10.1) for specific negative covenants affecting operations.
  • Monitor future borrowings under this facility to assess leverage changes.